Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.

Boivineau G, Zallot C, Zerbib F, Plastaras L, Amiot A, Boivineau L, Koch S, Peyrin-Biroulet L, Vuitton L

Open source

DOI
10.1093/ecco-jcc/jjac089
Published
2022 Dec 5
Container
Journal of Crohn's & colitis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjac089,
  title = {Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.},
  author = {Boivineau G and Zallot C and Zerbib F and Plastaras L and Amiot A and Boivineau L and Koch S and Peyrin-Biroulet L and Vuitton L},
  year = {2022},
  journal = {Journal of Crohn's \& colitis},
  doi = {10.1093/ecco-jcc/jjac089},
  url = {https://doi.org/10.1093/ecco-jcc/jjac089}
}

RIS

TY  - JOUR
TI  - Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.
AU  - Boivineau G
AU  - Zallot C
AU  - Zerbib F
AU  - Plastaras L
AU  - Amiot A
AU  - Boivineau L
AU  - Koch S
AU  - Peyrin-Biroulet L
AU  - Vuitton L
PY  - 2022
JO  - Journal of Crohn's & colitis
DO  - 10.1093/ecco-jcc/jjac089
UR  - https://doi.org/10.1093/ecco-jcc/jjac089
ER  - 

APA

G, B., C, Z., F, Z., L, P., A, A., L, B., S, K., L, P., & L, V. (2022). Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjac089

Source records